FDA Approval Activities for this Drug
TRANDOLAPRIL Tablet; 1MG MAVIK Abbott 020528 TRANDOLAPRIL Tablet; 2MG MAVIK Abbott 020528 TRANDOLAPRIL Tablet; 4MG MAVIK Abbott 020591 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Tablet, Extended Release; 1MG;240MG TARKA Abbott 020591 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Tablet, Extended Release; 2MG;180MG TARKA Abbott 020591 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Tablet, Extended Release; 2MG;240MG TARKA Abbott 020591 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Tablet, Extended Release; 4MG;240MG TARKA Abbott Mavik (trandolapril) Tablets, Abbott Laboratories | Trandolapril Tablets, Lupin Ltd., Tentative Approval | Trandolapril Tablet, Teva Pharma, Approval | Trandolapril Tablets, Cobalt Pharma, Approval | Trandolapril Tablets, Aurobindo Pharma, Approval | Trandolapril Tablets, InvaGen Pharma, Approval | Trandolapril Tablets, Lupin Ltd., Approval | Trandolapril Tablets, CorePharma, Approval | Trandolapril Tablets, Cipla Ltd., Approval | Tarka (trandolapril/verapamil hydrochloride) Extended Release Tablets, Abbott Labs, Labeling Revision | Trandolapril Tablets, Mylan Pharma, Approval | Trandolapril Tablets, Glenmark Generics Inc., USA, Approval | Trandolapril Tablets, Dr. Reddy's Laboratories, Ltd., Approval